The Cost of Locally Advanced Cervical Cancer in Thailand: an Empirical Study for Economic Analysis

OBJECTIVE: To evaluate cost of illness of locally advanced cervical cancer patients from societal perspective in three scenarios including completely cured without severe late side effects (S1), completely cured with late grade 3-4 gastrointestinal side effects (S2.1) or genitourinary side effects (...

Descripción completa

Detalles Bibliográficos
Autores principales: Katanyoo, Kanyarat, Riewpaiboon, Arthorn, Chaikledkaew, Usa, Thavorncharoensap, Montarat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858260/
https://www.ncbi.nlm.nih.gov/pubmed/34710993
http://dx.doi.org/10.31557/APJCP.2021.22.10.3171
_version_ 1784654212764794880
author Katanyoo, Kanyarat
Riewpaiboon, Arthorn
Chaikledkaew, Usa
Thavorncharoensap, Montarat
author_facet Katanyoo, Kanyarat
Riewpaiboon, Arthorn
Chaikledkaew, Usa
Thavorncharoensap, Montarat
author_sort Katanyoo, Kanyarat
collection PubMed
description OBJECTIVE: To evaluate cost of illness of locally advanced cervical cancer patients from societal perspective in three scenarios including completely cured without severe late side effects (S1), completely cured with late grade 3-4 gastrointestinal side effects (S2.1) or genitourinary side effects (S2.2), and disease recurrence and death (S3). METHODS: The incidence-based approach was conducted. The cost was calculated for 5-year time horizon starting for the treatment initiation. Direct medical costs were extracted from hospital database. Cost of using two-dimensional technique and three-dimensional conformal radiation therapy were calculated separately. Direct non-medical costs and indirect costs in terms of productivity loss were based on actual expenses from the interview of 194 locally advanced cervical cancer patients from two tertiary hospitals in Bangkok, during June to December 2019. All costs were converted to US dollar in 2019 values. RESULTS: For 5 years, cost of illness per patient for using two-dimensional technique and three-dimensional conformal radiation therapy were US $8,391 and US $10,418 for S1, US $18,018 and US $20,045 for S2.1, US $17,908 and US $19,936 for S2.2, and US $61,076 and US $63,103 for S3, respectively. The economic burden for newly diagnosed locally advanced cervical cancer patients in Thailand in 2018 was approximately US $129 million and US $131 million for using two-dimensional technique and three-dimensional conformal radiation therapy, respectively. Cost from S3 accounted for 70% of all total cost. Premature death was the most important cost driver of cost of illness accounted for 64 % of the total cost estimates. CONCLUSIONS: Cost of illness of locally advanced cervical cancer patients produced significant economic burden from societal perspective. Disease recurrence and early death from cancer was the most influential cause of this burden.
format Online
Article
Text
id pubmed-8858260
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-88582602022-04-04 The Cost of Locally Advanced Cervical Cancer in Thailand: an Empirical Study for Economic Analysis Katanyoo, Kanyarat Riewpaiboon, Arthorn Chaikledkaew, Usa Thavorncharoensap, Montarat Asian Pac J Cancer Prev Research Article OBJECTIVE: To evaluate cost of illness of locally advanced cervical cancer patients from societal perspective in three scenarios including completely cured without severe late side effects (S1), completely cured with late grade 3-4 gastrointestinal side effects (S2.1) or genitourinary side effects (S2.2), and disease recurrence and death (S3). METHODS: The incidence-based approach was conducted. The cost was calculated for 5-year time horizon starting for the treatment initiation. Direct medical costs were extracted from hospital database. Cost of using two-dimensional technique and three-dimensional conformal radiation therapy were calculated separately. Direct non-medical costs and indirect costs in terms of productivity loss were based on actual expenses from the interview of 194 locally advanced cervical cancer patients from two tertiary hospitals in Bangkok, during June to December 2019. All costs were converted to US dollar in 2019 values. RESULTS: For 5 years, cost of illness per patient for using two-dimensional technique and three-dimensional conformal radiation therapy were US $8,391 and US $10,418 for S1, US $18,018 and US $20,045 for S2.1, US $17,908 and US $19,936 for S2.2, and US $61,076 and US $63,103 for S3, respectively. The economic burden for newly diagnosed locally advanced cervical cancer patients in Thailand in 2018 was approximately US $129 million and US $131 million for using two-dimensional technique and three-dimensional conformal radiation therapy, respectively. Cost from S3 accounted for 70% of all total cost. Premature death was the most important cost driver of cost of illness accounted for 64 % of the total cost estimates. CONCLUSIONS: Cost of illness of locally advanced cervical cancer patients produced significant economic burden from societal perspective. Disease recurrence and early death from cancer was the most influential cause of this burden. West Asia Organization for Cancer Prevention 2021-10 /pmc/articles/PMC8858260/ /pubmed/34710993 http://dx.doi.org/10.31557/APJCP.2021.22.10.3171 Text en https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Katanyoo, Kanyarat
Riewpaiboon, Arthorn
Chaikledkaew, Usa
Thavorncharoensap, Montarat
The Cost of Locally Advanced Cervical Cancer in Thailand: an Empirical Study for Economic Analysis
title The Cost of Locally Advanced Cervical Cancer in Thailand: an Empirical Study for Economic Analysis
title_full The Cost of Locally Advanced Cervical Cancer in Thailand: an Empirical Study for Economic Analysis
title_fullStr The Cost of Locally Advanced Cervical Cancer in Thailand: an Empirical Study for Economic Analysis
title_full_unstemmed The Cost of Locally Advanced Cervical Cancer in Thailand: an Empirical Study for Economic Analysis
title_short The Cost of Locally Advanced Cervical Cancer in Thailand: an Empirical Study for Economic Analysis
title_sort cost of locally advanced cervical cancer in thailand: an empirical study for economic analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858260/
https://www.ncbi.nlm.nih.gov/pubmed/34710993
http://dx.doi.org/10.31557/APJCP.2021.22.10.3171
work_keys_str_mv AT katanyookanyarat thecostoflocallyadvancedcervicalcancerinthailandanempiricalstudyforeconomicanalysis
AT riewpaiboonarthorn thecostoflocallyadvancedcervicalcancerinthailandanempiricalstudyforeconomicanalysis
AT chaikledkaewusa thecostoflocallyadvancedcervicalcancerinthailandanempiricalstudyforeconomicanalysis
AT thavorncharoensapmontarat thecostoflocallyadvancedcervicalcancerinthailandanempiricalstudyforeconomicanalysis
AT katanyookanyarat costoflocallyadvancedcervicalcancerinthailandanempiricalstudyforeconomicanalysis
AT riewpaiboonarthorn costoflocallyadvancedcervicalcancerinthailandanempiricalstudyforeconomicanalysis
AT chaikledkaewusa costoflocallyadvancedcervicalcancerinthailandanempiricalstudyforeconomicanalysis
AT thavorncharoensapmontarat costoflocallyadvancedcervicalcancerinthailandanempiricalstudyforeconomicanalysis